SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.

EBioMedicine

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address:

Published: June 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149267PMC
http://dx.doi.org/10.1016/j.ebiom.2021.103401DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 vaccines
4
vaccines single
4
single dose
4
dose covid-19
4
covid-19 survivors
4
sars-cov-2
1
single
1
dose
1
covid-19
1
survivors
1

Similar Publications

This research investigates the moral frames employed by diverse Chinese-speaking "experts" on their Facebook public pages in relation to COVID-19 vaccines, leveraging Moral Foundations Theory for analysis. The analysis highlights that experts predominantly employ moral frames emphasizing care and authority in communicating COVID-19 vaccines. However, the moral frames of care, loyalty, and fairness are more effective in garnering public support.

View Article and Find Full Text PDF

Post-acute sequelae of COVID-19 (PASC) are a diverse set of symptoms and syndromes driven by dysfunction of multiple organ systems that can persist for years and negatively impact the quality of life for millions of individuals. We currently lack specific therapeutics for patients with PASC, due in part to an incomplete understanding of its pathogenesis, especially for non-pulmonary sequelae. Here, we discuss three animal models that have been utilized to investigate PASC: non-human primates (NHPs), hamsters, and mice.

View Article and Find Full Text PDF

The emergence of new variants and diverse vaccination regimens have raised uncertainty about vaccine effectiveness against SARS-CoV-2. This study aims to investigate the impact of Omicron primo-/reinfection and primary vaccination schedules on the immunogenicity of an mRNA-based booster dose over a six-month period. We conducted a prospective cohort study to assess the durability and level of antibodies of 678 healthcare workers fully vaccinated against COVID-19.

View Article and Find Full Text PDF

SARS-CoV-2, the virus responsible for COVID-19, has undergone significant genetic evolution since its emergence in 2019. This study examines the genomic diversity of SARS-CoV-2 in Brazil after the worst phase of the pandemic, the wider adoption of routine vaccination, and the abolishment of other non-pharmacological preventive measures from July 2022 to July 2024 using 55,951 sequences retrieved from the GISAID database. The analysis focuses on the correlation between confirmed COVID-19 cases, sequencing efforts across Brazilian states, and the distribution and evolution of viral lineages.

View Article and Find Full Text PDF

The present study aimed to evaluate the vaccine effectiveness (VE) of different doses of an inactivated coronavirus disease 2019 (COVID-19) vaccine against Omicron BA.2.2 infection in Beijing, China, 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!